Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit)

v3.25.1
Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Convertible Preferred Stock [Member]
Temporary Equity, Balance (in shares) at Dec. 31, 2022             15,360,787
Temporary Equity, Balance at Dec. 31, 2022             $ 70,603
Balance (in shares) at Dec. 31, 2022     1,770,167        
Balance at Dec. 31, 2022 $ (93,777) $ 0 $ 2 $ 1,213 $ 0 $ (94,992)  
Stock-based compensation 603 0 0 603 0 0  
Net Income (Loss) $ 18,691 $ 0 $ 0 0 0 18,691  
Temporary Equity, Balance (in shares) at Dec. 31, 2023 15,360,787           15,360,787
Temporary Equity, Balance at Dec. 31, 2023 $ 70,603           $ 70,603
Balance (in shares) at Dec. 31, 2023   0 1,770,167        
Balance at Dec. 31, 2023 (74,483) $ 0 $ 2 1,816 0 (76,301)  
Temporary equity, Conversion of convertible preferred stock into common stock in connection with Reverse Merger (in shares)             (15,360,787)
Temporary equity, Conversion of convertible preferred stock into common stock in connection with Reverse Merger             $ (70,603)
Conversion of convertible preferred stock into common stock in connection with Reverse Merger (in shares)     4,753,650        
Conversion of convertible preferred stock into common stock in connection with Reverse Merger 70,603 0 $ 5 70,598 0 0  
Conversion of convertible notes into common stock and prefunded warrants in connection with Reverse Merger (in shares)     1,179,163        
Conversion of convertible notes into common stock and prefunded warrants in connection with Reverse Merger 17,762 0 $ 1 17,761 0 0  
Issuance of common stock and prefunded warrants in connection with PIPE (In Shares)     1,988,885        
Issuance of common stock and prefunded warrants in connection with PIPE 56,189 $ 0 $ 2 56,187 0 0  
Issuance of preferred stock and common stock to former stockholders of Pieris in connection with Reverse Merger (in shares)   15,617 1,320,240        
Issuance of preferred stock and common stock to former stockholders of Pieris in connection with Reverse Merger 11,611 $ 0 $ 1 11,610 0 0  
Transactions costs associated with the Reverse Merger (2,474) 0 0 (2,474) 0 0  
Stock-based compensation 830 0 0 830   0  
Foreign currency translation gain 3 0 0 0 3 0  
Net Income (Loss) $ (17,434) $ 0 $ 0 0 0 (17,434)  
Temporary Equity, Balance (in shares) at Dec. 31, 2024 0           0
Temporary Equity, Balance at Dec. 31, 2024 $ 0           $ 0
Balance (in shares) at Dec. 31, 2024   15,617 11,012,105        
Balance at Dec. 31, 2024 $ 62,607 $ 0 $ 11 $ 156,328 $ 3 $ (93,735)